Status:
TERMINATED
Spectral CT Clinical Trial
Lead Sponsor:
Philips (China) Investment CO., LTD
Conditions:
Adult ALL
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The objective of this clinical trial was to evaluate the efficacy, ease of operation, stability, and safety of Spectral CT as expected.
Detailed Description
Under the premise of protecting subjects and ensuring the scientific nature of this clinical trial, Spectral CT was evaluated for its effectiveness, convenience, stability and safety under normal cond...
Eligibility Criteria
Inclusion
- Volunteers (ages 18 to 75);
- Negative pregnancy tests for women of childbearing age;
- Agree to participate in the clinical trial and sign the subject informed consent form;
- Enhanced scan requires laboratory evidence of normal renal function.
Exclusion
- The body cannot comply with CT examination;
- Pregnant and lactating women;
- Claustrophobia;
- People who are not suitable for enhanced scanning with iodine contrast agent (previous severe heart failure and hyperthyroidism, iodine contrast agent allergy and susceptibility);
- Patients deemed unsuitable for participation in this clinical trial by the investigator.
Key Trial Info
Start Date :
March 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2023
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT05361356
Start Date
March 10 2022
End Date
February 27 2023
Last Update
April 7 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, China
2
Nanfang Hospital
Guangzhou, China
3
The First Hospital of Xian Jiaotong University
Xi'an, China